[1]
|
段涛, 杨慧霞, 胡娅莉, 漆洪波, 孙路明, 郑明明. 胎儿生长受限专家共识(2019版) [J]. 中国产前诊断杂志(电子版), 2019, 11(4): 78-98.
|
[2]
|
Kehl, S., Dotsch, J., Hecher, K., Schlembach, D., Schmitz, D., Stepan, H., et al. (2017) Intrauterine Growth Restriction. Guide-Line of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016). Geburtshilfe Frauenheilkd, 77, 1157-1173. https://doi.org/10.1055/s-0043-118908
|
[3]
|
Ray, J.G., Vermeulen, M.J., Schull, M.J. and Redelmeier, D.A. (2005) Cardiovascular Health after Maternal Placental Syndromes (CHAMPS): Population-Based Retrospective Cohort Study. Lancet, 366, 1797-1803.
https://doi.org/10.1016/S0140-6736(05)67726-4
|
[4]
|
Barker, D.J. (2006) Adult Consequences of Fetal Growth Restriction. Clinical Obstetrics and Gynecology, 49, 270-283.
|
[5]
|
Jain, V. (2015) Letter to the Editor: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary. Journal d’obstétrique et gynécologie du Canada, 37, 774-775.
https://doi.org/10.1016/S1701-2163(15)30145-6
|
[6]
|
Nuriyeva, G., Kose, S., Tuna, G., Kant, M., Akis, M., Altunyurt, S., et al. (2017) A Prospective Study on First Trimester Prediction of Ischemic Placental Diseases. Prenatal Diagnosis, 37, 341-349. https://doi.org/10.1002/pd.5017
|
[7]
|
Zhong, Y., Zhu, F. and Ding, Y. (2015) Serum Screening in fiRst Trimester to Predict Pre-Eclampsia, Small for Gestational Age and Preterm Delivery: Systematic Review and Meta-Analysis. BMC Pregnancy Childbirth, 15, Article No. 191. https://doi.org/10.1186/s12884-015-0608-y
|
[8]
|
Conde-Agudelo, A., Papageorghiou, A., Kennedy, S. and Villar, J. (2013) Novel Biomarkers for Predicting Intrauterine Growth Restriction: A Systematic Review and Meta-Analysis. BJOG, 120, 681-694.
https://doi.org/10.1111/1471-0528.12172
|
[9]
|
Espinoza, J., Romero, R., Nien, J.K., Gomez, R., Kusanovic, J.P., Gonçalves, L.F., et al. (2007) Identification of Patients at Risk for Early Onset and/or Severe Preeclampsia with the Use of Uterineartery Doppler Velocimetry and Placental Growth Factor. American Journal of Obstetrics & Gynecology, 196, 326.e321-326.e313.
https://doi.org/10.1016/j.ajog.2006.11.002
|
[10]
|
Benton, S.J., Mccowan, L.M., Heazell, A.E., Grynspan, D., Hutcheon, J.A., Senger, C., et al. (2016) Placental Growth Factor as a Marker of Fetal Growth Restriction Caused by Placental Dysfunction. Placenta, 42, 1-8.
https://doi.org/10.1016/j.placenta.2016.03.010
|
[11]
|
Villa, P.M., Hämäläinen, E., Mäki, A., Räikkönen, K., Pesonen, A.K., Taipale, P., et al. (2013) Vasoactive Agents for the Prediction of Early- and Late-Onset Preeclampsia in a High-Risk Cohort. BMC Pregnancy Childbirth, 13, Article No. 110. https://doi.org/10.1186/1471-2393-13-110
|
[12]
|
Visan, V., Scripcariu, I.S., Socolov, D., Costescu, A., Rusu, D., Socolov, R., et al. (2019) Better Prediction for FGR (Fetal Growth Restriction) with the sFlt-1/PIGF Ratio: A Case-Control Study. Medicine, 98, e16069.
|
[13]
|
Lawrence, J.B., Oxvig, C., Overgaard, M.T., et al. (1999) The Insulin-Like Growthfactor (IGF)-Dependent IGF Binding Protein-4 Protease Secreted Byhuman Fibroblasts Is Pregnancy-Associated Plasma Protein-A. Proceedings of the National Academy of Sciences of the United States of America, 96, 3149-3153. https://doi.org/10.1073/pnas.96.6.3149
|
[14]
|
Tong, S., Kaitu'u-Lino, T.J., Walker, S.P. and MacDonald, T.M. (2019) Blood-Based Biomarkers in the Maternal Circulation Associated with Fetal Growth Restriction. Prenatal Diagnosis, 39, 947-949. https://doi.org/10.1002/pd.5525
|
[15]
|
Duan, H., Zhao, G., Xu, B., Hu, S. and Li, J. (2017) Maternal Serum PLGF, PAPPA, Beta-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia. Clinical Laboratory, 63, 921-925.
https://doi.org/10.7754/Clin.Lab.2016.161103
|
[16]
|
彭继文, 李佩佩, 徐怡然, 诸珍珍, 叶玲丽. 孕早期PAPP-A、β-HCG、Hcy等多参数综合评估胎儿生长受限的价值[J]. 生殖医学杂志, 2020, 29(11): 1477-1482.
|
[17]
|
Karagiannis, G., Akolekar, R., Sarquis, R., Wright, D. and Nicolaides, K.H. (2011) Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11-13 Weeks. Fetal Diagnosis and Therapy, 29, 148-154.
https://doi.org/10.1159/000321694
|
[18]
|
Dugoff, L., Hobbins, J.C, Malone, F.D., Porter, T.F., Luthy, D., Comstock, C.H., et al. (2004) First-Trimester Maternal Serum PAPP-A and Free-Beta Subunit Human Chorionic Gonadotropin Concentrations and Nuchal Translucency Are Associated with Obstetric Complications: A Population-Based Screening Study (The FASTER Trial). The American Journal of Obstetrics and Gynecology, 191, 1446-1451. https://doi.org/10.1016/j.ajog.2004.06.052
|
[19]
|
Taher, S.I., and Alalaf, S.K. (2019) Association between Serum Beta-Human Chorionic Gonadotropin and Preeclampsia and Its Effects on Perinatal and Maternal Outcomes: A Case Control Study. Archives of Gynecology and Obstetrics, 299, 713-718. https://doi.org/10.1007/s00404-019-05041-y
|
[20]
|
Sharony, R., Sharon-Weiner, M., Kidron, D., Sukenik-Halevy, R., Biron-Shental, T., Manor, M., et al. (2018) The Association between Maternal Serum First Trimester Free BetahCG, Second Trimester Intact hCG Levels and Foetal Growth Restriction and Preeclampsia. Journal of Obstetrics and Gynaecology, 38, 363-366.
https://doi.org/10.1080/01443615.2017.1340441
|
[21]
|
苗治晶, 乌兰. 血小板功能在胎儿生长受限患者的变化及诊断效能研究[J]. 实用妇科内分泌电子杂志, 2019, 6(34): 6-8.
|
[22]
|
Briana, D.D. and Malamitsi-Puchner, A. (2021) Intrauterine Growth Restriction: The Controversial Role of Perinatal Adipocytokines in the Prediction of Metabolic Adult Disease. The Journal of Maternal-Fetal & Neonatal Medicine, 34, 2577-2582. https://doi.org/10.1080/14767058.2019.1669556
|
[23]
|
Kaitu’u-Lino, T.J., Tong, S., Walker, S.P., MacDonald, T.M., Cannon, P., Nguyen, T.V., et al. (2021) Maternal Circulating SPINT1 Is Reduced in Small-for-Gestational Age Pregnancies at 26 Weeks: Growing up in Singapore towards Health Outcomes (GUSTO) Cohort Study. Placenta, 110, 24-28. https://doi.org/10.1016/j.placenta.2021.05.007
|
[24]
|
黄玉莲, 罗晓华, 谷存华, 郭晓珮. PS、PC和AT-III在胎儿生长受限中的诊疗价值[J]. 中外医学研究, 2021, 19(2): 71-73.
|
[25]
|
Xu, C., Guo, Z., Zhang, J., Lu, Q., Tian, Q., Liu, S., et al. (2021) Non-Invasive Prediction of Fetal Growth Restriction by Whole-Genome Promoter Profiling of Maternal Plasma DNA: A Nested Case-Control Study. BJOG, 128, 458-466.
https://doi.org/10.1111/1471-0528.16292
|
[26]
|
Hromadnikova, I., Dvorakova, L., Kotlabova, K. and Krofta, L. (2019) The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs. International Journal of Molecular Sciences, 20, Article No. 2972. https://doi.org/10.3390/ijms20122972
|
[27]
|
Skalis, G., Katsi, V., Miliou, A., Georgiopoulos, G., Papazachou, O., Vamvakou, G., Nihoyannopoulos, P., Tousoulis, D. and Makris, T. (2019) MicroRNAs in Preeclampsia. Microrna, 8, 28-35.
https://doi.org/10.2174/2211536607666180813123303
|
[28]
|
ten Dijke, P., Goumans, M.J. and Pardali, E. (2008) Endoglin in Angiogenesis and Vascular Diseases. Angiogenesis, 11, 79-89. https://doi.org/10.1007/s10456-008-9101-9
|
[29]
|
Oujo, B., Perez-Barriocanal, F., Bernabeu, C. and Lopez-Novoa, J.M. (2013) Membrane and Soluble forms of Endoglin in Preeclampsia. Current Molecular Medicine, 13, 1345-1357. https://doi.org/10.2174/15665240113139990058
|
[30]
|
Nogueira Reis, Z.S., Pereira, J.B., Costa, L.A.C. and Barra, J.S. (2020) Soluble Endoglin in Urine as an Early-Pregnancy Preeclampsia Marker: Antenatal Longitudinal Feasibility Study. Journal of Obstetrics and Gynaecology, 19, 693-698.
|
[31]
|
Margioula-Siarkou, G., Margioula-Siarkou, C., Petousis, S., Margaritis, K., Alexandratou, M., Dinas, K., Sotiriadis, A. and Mavromatidis, G. (2021) Soluble Endoglin Concentration in Maternal Blood as a Diagnostic Biomarker of Preeclampsia: A Systematic Review and Meta-Analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 258, 366-381. https://doi.org/10.1016/j.ejogrb.2021.01.039
|
[32]
|
Zhao, W., Qiao, J., Zhang, Q., Zhao, Y. and Chen, Q. (2010) Levels of Antiangiogenic Factors in Preeclamptic Pregnancies. Growth Factors, 28, 293-298. https://doi.org/10.3109/08977191003662651
|
[33]
|
Singh, T., Leslie, K., Bhide, A., D’Antonio, F. and Thilaganathan, B. (2012) Role of Second-Trimester Uterine Artery Doppler in Assessing Stillbirth Risk. Obstetrics & Gynecology, 119, 256-261.
https://doi.org/10.1097/AOG.0b013e318242ad81
|
[34]
|
Lakshmy, S.R., Praveenkumar, M., Shobana, U. and Thasleem, Z. (2017) Uterine Artery Doppler: Changing Concepts in Prediction and Prevention of PE and FGR. Journal of Fetal Medicine, 5, 93-105.
https://doi.org/10.1007/s40556-017-0150-2
|
[35]
|
张利琴. 妊娠晚期母体子宫动脉和胎儿脐动脉血流参数预测胎儿生长受限及评估胎儿预后的价值[J]. 中国妇幼保健, 2021, 36(10): 2425-2428.
|
[36]
|
李宁, 李安洋, 赵亚东, 余亮. 孕晚期胎儿脐动脉、大脑中动脉及子宫动脉血流参数对FGR的诊断价值[J]. 皖南医学院学报, 2021, 40(1): 72-75.
|
[37]
|
Adekanmi, A.J., Roberts, A., Akinmoladun, J.A. and Adeyinka, A.O. (2019) Uterine and Umbilical Artery Doppler in Women with Pre-Eclampsia and Their Pregnancy Outcomes. Nigerian Postgraduate Medical Journal, 26, 106-112.
https://doi.org/10.4103/npmj.npmj_161_18
|
[38]
|
钟素霞. 超声多普勒检测UA及MCA血流参数预测胎儿FGR [J]. 吉林医学, 2014, 35(14): 3002-3003.
|
[39]
|
Ozeren, M., Dinç, H., Ekmen, U., Senekayli, C. and Aydemir, V. (1999) Umbilical and Middle Cerebral Artery Doppler Indices in Patients with Preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology, 82, 11-16. https://doi.org/10.1016/S0301-2115(98)00167-5
|
[40]
|
Khalil, A., Morales-Rosello, J., Khan, N., Nath, M., Agarwal, P., Bhide, A., Papageorghiou, A., et al. (2017) Is Cerebroplacental Ratio a Marker of Impaired Fetal Growth Velocity and Adverse Pregnancy Outcome? American Journal of Obstetrics and Gynecology, 216, 606.e1-606.e10. https://doi.org/10.1016/j.ajog.2017.02.005
|
[41]
|
Novac, M.V., Moldoveanu, A., Tudorache, Ş., Oprescu, N.D., Miescu, M., Siminel, M.A., Vrabie, S., Novac, M.B. and Iliescu, D.G. (2017) Utility of Cerebroplacental Ratio in IUGR Fetuses from Pregnancy with Preeclampsia in Prediction the Risk for Perinatal Complications. Current Health Sciences Journal, 43, 231-235.
|
[42]
|
韩磊, 高燕华, 王珍芳, 彭建美, 韦爱华, 管湘平. 三维能量多普勒超声对晚孕期胎盘植入的诊断价值[J]. 临床与病理杂志, 2016, 36(10): 1616-1619.
|
[43]
|
Yakovenko, K., Tamm, T. and Yakovenko, Y. (2018) A Study of U-Terine Hemodynamics Using Three-Dimensional Power Doppler Sonography in Patients with Adenomyosis. Georgian Med News, 5, 21-27.
|
[44]
|
李娟, 张颍, 翟莉丽, 王倩, 钱同刚, 冯晓明. 四维能量多普勒超声在胎儿生长受限预测中的可行性分析[J]. 中国煤炭工业医学杂志, 2021, 24(2): 132-136.
|